Effectiveness of SARS-CoV-2 vaccines on hemodialysis patients in Japan: A nationwide cohort study.
Kan KikuchiMasaomi NangakuMunekazu RyuzakiTomoyuki YamakawaOta YoshihiroNorio HanafusaKen SakaiYoshihiko KannoRyoichi AndoToshio ShinodaShu WakinoHidetomo NakamotoYoshiaki TakemotoTadao Akizawanull nullPublished in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2022)
Our prospective observational study showed that SRAS-CoV-2 vaccination in hemodialysis patients is vital for reducing need of oxygen supplementation and mortality risk.